The FDA plans to publish a draft guidance in early 2018 clarifying what degree of “acceptable uncertainty” is allowable when evaluating medical devices during premarket review, FDA ...

Medical device manufacturers will now need to submit a plan to monitor, identify and address post-market cybersecurity vulnerabilities when applying for new pre-market authorizations, according to ...